Veeva Systems (NYSE:VEEV) & KORU Medical Systems (NASDAQ:KRMD) Critical Survey

KORU Medical Systems (NASDAQ:KRMD) and Veeva Systems (NYSE:VEEV) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, profitability, valuation, dividends and risk.

Risk and Volatility

KORU Medical Systems has a beta of 0.42, suggesting that its share price is 58% less volatile than the S&P 500. Comparatively, Veeva Systems has a beta of 0.98, suggesting that its share price is 2% less volatile than the S&P 500.

Profitability

This table compares KORU Medical Systems and Veeva Systems’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
KORU Medical Systems	-12.24%	-26.77%	-16.81%
Veeva Systems	27.29%	13.72%	11.23%

Earnings & Valuation

This table compares KORU Medical Systems and Veeva Systems”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KORU Medical Systems	$39.07 million	6.88	-$6.07 million	($0.08)	-72.51
Veeva Systems	$3.08 billion	12.79	$714.14 million	$5.14	46.75

Veeva Systems has higher revenue and earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Veeva Systems, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

58.6% of KORU Medical Systems shares are held by institutional investors. Comparatively, 88.2% of Veeva Systems shares are held by institutional investors. 20.6% of KORU Medical Systems shares are held by insiders. Comparatively, 10.3% of Veeva Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Analyst Recommendations

This is a summary of current ratings and target prices for KORU Medical Systems and Veeva Systems, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KORU Medical Systems	1	1	2	1	2.60
Veeva Systems	2	6	20	0	2.64

KORU Medical Systems currently has a consensus target price of $4.83, suggesting a potential downside of 16.68%. Veeva Systems has a consensus target price of $305.88, suggesting a potential upside of 27.30%. Given Veeva Systems’ stronger consensus rating and higher possible upside, analysts clearly believe Veeva Systems is more favorable than KORU Medical Systems.

Summary

Veeva Systems beats KORU Medical Systems on 13 of the 15 factors compared between the two stocks.

About KORU Medical Systems

KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.

About Veeva Systems

Veeva Systems Inc. provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States. The company also provides Veeva Development Cloud, a suite of applications for the clinical, regulatory, quality, and safety functions, including Veeva Vault Clinical, Veeva Vault RIM, Veeva Vault Safety, and Veeva Vault Quality; Veeva QualityOne, a quality and document management, and training solution; Veeva RegulatoryOne, a solution that helps companies to manage regulatory submission content; and Veeva Claims addresses the end-to-end product and marketing claims management process. In addition, it offers professional and support services, including implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; data migration and systems integrations technical consulting services; training on its solutions; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.